Radiolabeling and preclinical animal model evaluation of DTPA coupled 99m Tc-labelled flutamide complex ([ 99m Tc]DTPA-FLUT) as a potential radiotracer for cancer imaging
Acta Radiologica · 2024
DOI: 10.1177/02841851241249161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Radiologica, 2024. Verfasst von Syed Ali Raza Naqvi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Government College University Faisalabad, Faisalabad, Punjab, Pakistan. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Technetium Tc 99m Pentetate, Flutamide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Advances in molecular imaging strategies have had an effect on precise diagnosis and treatment. Research has been intensified to develop more effective and versatile radiopharmaceuticals to uplift diagnostic efficiency and, consequently, the treatment.
Purpose
To label the flutamide (FLUT) coupled with diethylenetriamine pentaacetate (DTPA) with technetium-99 m ( 99m Tc) and to evaluate its binding efficiency with rhabdomyosarcoma (RMS) cancer cells. Material and methods Radiolabeling of FLUT with 185 MBq freshly eluted 99m TcO 4 −1 was carried out via DTPA bifunctional chelating agent using stannous chloride reducing agent at pH 5. The labeled compound was assessed for its purity using chromatography analysis, stability in saline and blood serum, AND charge using paper electrophoresis. Normal biodistribution was studied using a mouse model, while binding affinity with RMS cancer cells was studied using an internalization assay. The in vivo accumulation of RMS cancer cells in a rabbit model was monitored using a SPECT gamma camera.
Results
Radiolabeling reaction displayed a pharmaceutical yield of 97% and a stability assay showed >95% intact radiopharmaceutical up to 6 h in saline and blood serum. In vitro internalization studies showed the potential of [ 99m Tc]DTPA-FLUT to enter into cancer cells. This biodistribution study showed rapid blood clearance and minimum uptake by body organs, and scintigraphy displayed the [ 99m Tc]DTPA-FLUT uptake by lesion, induced by RMS cancer cell lines in rabbit.
Conclusion
Stable, newly developed [ 99m Tc]DTPA-FLUT seeks its way to internalize into RMS cancer cells, indicating it could be a potential candidate for the diagnosis of RMS cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Government College University Faisalabad, Faisalabad, Punjab, Pakistan.
- Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan.
- Department of Chemistry, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan.
- Institute of Chemistry, University of Okara, Okara, Punjab, Pakistan.
ORCID-Profile: Syed Ali Raza Naqvi
Zitieren
APA
Naqvi, S. A. R., Hassan, A. J., Janjua, M. R. S. A., Abbas, N., Zahoor, A. F., Hassan, S. U., & Hussain, A. (2024). Radiolabeling and preclinical animal model evaluation of DTPA coupled 99m Tc-labelled flutamide complex ([ 99m Tc]DTPA-FLUT) as a potential radiotracer for cancer imaging. Acta Radiologica. https://doi.org/10.1177/02841851241249161
Vancouver
Naqvi SAR, Hassan AJ, Janjua MRSA, Abbas N, Zahoor AF, Hassan SU, et al. Radiolabeling and preclinical animal model evaluation of DTPA coupled 99m Tc-labelled flutamide complex ([ 99m Tc]DTPA-FLUT) as a potential radiotracer for cancer imaging. Acta Radiologica. 2024. doi:10.1177/02841851241249161
BibTeX
@article{Naqvi2024,
author = {Naqvi, Syed Ali Raza and Hassan, Ahmad Junaid and Janjua, Muhammad Ramzan Saeed Ashraf and Abbas, Naseem and Zahoor, Ameer Fawad and Hassan, Sadaf Ul and Hussain, Amjad},
title = {Radiolabeling and preclinical animal model evaluation of DTPA coupled 99m Tc-labelled flutamide complex ([ 99m Tc]DTPA-FLUT) as a potential radiotracer for cancer imaging},
journal = {Acta Radiologica},
year = {2024},
doi = {10.1177/02841851241249161}
}
EUVIMED